These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23330355)

  • 21. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey.
    Ertas G; Ucer AR; Altundag MB; Durmus S; Calikoglu T; Ozbagi K; Abanuz H; Altundag K; Demirkasimoglu A
    Med Oncol; 2008; 25(1):69-72. PubMed ID: 18188718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mixed medulloblastoma and spongioblastoma of the cerebellum with spread to the cerebrum and spinal cord.
    TEITELBAUM HA; PHILLIPS RE
    Dis Nerv Syst; 1948 Sep; 9(9):283-9. PubMed ID: 18881928
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
    Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding medulloblastoma.
    Quinlan A; Rizzolo D
    JAAPA; 2017 Oct; 30(10):30-36. PubMed ID: 28953021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyzing factors influencing medulloblastoma prognosis.
    Watt TJ; Winfield JA
    J Neurosurg; 1987 Sep; 67(3):471-2. PubMed ID: 3612282
    [No Abstract]   [Full Text] [Related]  

  • 27. Medulloblastoma.
    Padovani L; André N; Gentet JC; Muracciole X
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S338. PubMed ID: 21944006
    [No Abstract]   [Full Text] [Related]  

  • 28. Medulloblastoma: presentation, diagnosis and management.
    Packer RJ; Finlay JL
    Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modern aspects of treatment of medulloblastomas/primitive neuroectodermal tumors of the posterior cranial fossa in children].
    Nagulić M; Popović V; Barjaktarević ; Golubicić I
    Srp Arh Celok Lek; 1991; 119(7-8):190-3. PubMed ID: 1792575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medulloblastoma and neuroblastoma in adults.
    Blijham GH; Barlogie B; Richman S; Latreille J; Vellekoop L
    Neth J Med; 1982; 25(4):94-9. PubMed ID: 7088229
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medulloblastoma in pediatrics. Current prognosis and treatment].
    Rivera-Luna R; Niembro-Zúñiga AM; Zarco A; Marhx-Bracho A; Cárdenas-Cardós R; Olaya-Vargas A; Rueda-Franco F; Martínez-Avalos A
    Gac Med Mex; 2007; 143(5):415-20. PubMed ID: 18246935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
    Brandes AA; Franceschi E; Tosoni A; Reni M; Gatta G; Vecht C; Kortmann RD
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):165-79. PubMed ID: 19303318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medulloblastoma with extensive nodularity: a report of two cases.
    Hellbusch LC; Robinson MN; McComb RD; Gordon BG; Meyer RC
    Pediatr Neurosurg; 2008; 44(5):430-2. PubMed ID: 18703894
    [No Abstract]   [Full Text] [Related]  

  • 34. The management of children and adolescents with medulloblastoma in low and middle income countries.
    Gajjar A; Finlay JL
    Pediatr Blood Cancer; 2015 Apr; 62(4):549-50. PubMed ID: 25545387
    [No Abstract]   [Full Text] [Related]  

  • 35. Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.
    Allen JC; Epstein F
    J Neurosurg; 1982 Oct; 57(4):446-51. PubMed ID: 7108593
    [No Abstract]   [Full Text] [Related]  

  • 36. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
    Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
    J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of medulloblastoma in children and adolescents.
    Collange NZ; Brito Sde A; Campos RR; Santos EA; Botelho RV
    Rev Assoc Med Bras (1992); 2016 Jul; 62(4):297. PubMed ID: 27437671
    [No Abstract]   [Full Text] [Related]  

  • 38. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.
    Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of medulloblastoma in children and adolescents.
    Collange NZ; Brito Sde A; Campos RR; Santos EA; Botelho RV;
    Rev Assoc Med Bras (1992); 2016 Jul; 62(4):298-302. PubMed ID: 27437672
    [No Abstract]   [Full Text] [Related]  

  • 40. Medulloblastoma: new insights into biology and treatment.
    Pizer B; Clifford S
    Arch Dis Child Educ Pract Ed; 2008 Oct; 93(5):137-44. PubMed ID: 18809691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.